Progress Analysis of Personalized Antiplatelet Therapy in Patients with Coronary Heart Disease Undergoing Interventional Therapy
Coronary atherosclerosis (or coronary heart disease [CHD]) is a common cardiovascular disease that seriously damages human health. Percutaneous coronary stent implantation represents the primary treatment option for severe CHD in clinical practice; meanwhile, dual antiplatelet therapy (DAPT) is wide...
Saved in:
| Main Authors: | Ji-tong Yang, Qiu-juan Zhang, Hua Li, Ming-wei Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2024-12-01
|
| Series: | Reviews in Cardiovascular Medicine |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/RCM/25/12/10.31083/j.rcm2512462 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) in patients with chronic coronary artery disease (CAD) - current state of knowledge and perspective for further research
by: Hubert Bochenek, et al.
Published: (2025-02-01) -
Short vs Standard Duration Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with New-Generation Drug-Eluting Stents: A Meta- Analysis
by: Inam Ullah, et al.
Published: (2024-10-01) -
Dual Antiplatelet Therapy Regimens and Duration for Intracranial Stenting Procedures: Literature Review
by: Milda Paliulytė, et al.
Published: (2023-11-01) -
Real-world Data of Antithrombotic Therapy in Neuroendovascular Therapy: Analysis of JR-NET 4
by: Nozomi SASAKI, et al.
Published: (2024-12-01) -
Breaking boundaries: Ticagrelor monotherapy in high-risk patients
by: Balbir Singh, et al.
Published: (2024-12-01)